22.03.2019 • NewsElaine BurridgeHaldor TopsoeTemasek

Temasek Takes Stake in Haldor Topsoe

Temasek Takes Stake in Haldor Topsoe (c) Haldor Topsoe
Temasek Takes Stake in Haldor Topsoe (c) Haldor Topsoe

Singapore investment company Temasek has agreed to buy a 30% stake in Danish catalyst and technology company Haldor Topsoe. Financial terms were not disclosed.

The transaction is expected to close later this year. Haldor Topsoe Holding, which is 100% owned by the Topsoe family, will remain the long-term majority shareholder.

The Lyngby-headquartered company said it selected Temasek because of the value it would add through its deep insights and connections in Asian and other emerging growth markets, including China.

“We are extremely pleased to welcome Temasek as our new minority shareholder in Haldor Topsoe. As a commercial investor, Temasek’s capital will further enhance our considerable growth potential organically and through potential acquisitions,” said Jakob Haldor Topsoe, chairman of the board of directors at Haldor Topsoe Holding.

Bjerne Clausen, CEO of Haldor Topsoe, added that Topsoe is in a strong market position and ready for growth after some years of consolidation and restructuring.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.